PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar]
Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…
CertaraFebruary 27, 2025
Combining mechanistic modeling with machine learning as a strategy to predict inflammatory bowel disease clinical scores
In this paper, we discuss a method to integrate simulated markers of inflammation from a…
CertaraFebruary 27, 2025
Accelerating CMC Success in Rare Disease Drug Development
New drug approvals in rare diseases are rising, bringing hope to patients. But with accelerated…
CertaraFebruary 26, 2025
Leveraging Real-World Evidence (RWE) in Rare Disease Drug Development
The path to regulatory approval and market access for rare disease therapies presents unique challenges.…
CertaraFebruary 26, 2025
Bridging Global Health Disparities in Rare Disease Drug Development
Rare diseases know no borders—but access to life-changing treatments remains unequal across the world. In…
CertaraFebruary 26, 2025
Advancing Rare Disease Therapies: The Power of Regulatory Expertise
Bringing treatments to patients with rare diseases has long been one of the biggest challenges…
CertaraFebruary 26, 2025
How Biosimulation is Transforming Rare Disease Drug Development
Developing therapeutics for rare diseases comes with unique challenges—small patient populations, high variability in treatment…
CertaraFebruary 26, 2025
Gene Therapy: A Transformative Shift in Rare Disease Treatment
After decades of promise, gene therapy is finally starting to deliver on its potential—especially for…
CertaraFebruary 26, 2025
